BioWorld

June 13, 2002

BIO 2002 Conference Concludes; Washington Is Industry's Next Stop

TORONTO - The third and final day of the Biotechnology Industry Organization's International Biotechnology Convention & Exhibition began with rain. Read More

Panel: Confess About Failures, Then Push Research Onward

Deadly Gut Bug, Enterococcus faecalis, Hints At Drug Targets Against Antibiotic Resistance

ISTA Plans To Raise $30M, Start Vitrase NDA This Year

FBI Nabs ImClone's Waksal; $10M Bond On SEC Charges

Bush Signs New PDUFA With Anti-Terrorism Bill

Millennium's Velcade Entering Phase III For Multiple Myeloma

Antibodies Charging Ahead With Smart' New Methods

Brownback May Compromise On Senate Cloning Measure

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for Jan 23, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Jan. 23, 2026.

Illustration of human body surrounded by DNA, cell and drug icons

Cell/gene therapy sector now sustainable; China competition mounting

BioWorld

There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...

Illustration of magnifying glass inspecting brain

Neurotrimin unveiled as marker in intellectual disability

BioWorld Science

Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...

DNA mutations or genetic disorder concept art

Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease

BioWorld Science

Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...